AI Assistant
Blog
Pricing
Log In
Sign Up
The Biosimilar CT-P13 Infliximab Is More Immunogenic Than the Original Infliximab In Iraqi Patients with Ankylosing Spondylitis
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
